Atherosclerosis

These are our consortia focussing on various aspects of cardiomyopathy.

Generating the best evidence-based pharmaceutical targets and drugs for atherosclerosis

Inflammatory Reprogramming by Ageing and Microbiome – Targets for Treatment of Cardiovascular Disease

Targeting energy metabolism to comBAT cardiovascular disease